BDBM50246351 (+/-)-1-(4-(1-(4-(1H-pyrrolo[2,3-b]pyridin-3-yl)piperidin-1-yl)-2-hydroxyethyl)piperidin-1-yl)-3-(3,5-difluorophenyl)prop-2-en-1-one::CHEMBL508015
SMILES: OCC(C1CCN(CC1)C(=O)C=Cc1cc(F)cc(F)c1)N1CCC(CC1)c1c[nH]c2ncccc12
InChI Key: InChIKey=JWWBRTLPEUWQCU-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-C chemokine receptor type 2 (Homo sapiens (Human)) | BDBM50246351 ((+/-)-1-(4-(1-(4-(1H-pyrrolo[2,3-b]pyridin-3-yl)pi...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL | Assay Description Antagonist activity at human CCR2 | Bioorg Med Chem Lett 18: 6468-70 (2008) Article DOI: 10.1016/j.bmcl.2008.10.061 BindingDB Entry DOI: 10.7270/Q2V40V1J | |||||||||||
More data for this Ligand-Target Pair |